Literature DB >> 8728539

Muscarinic antagonists are anxiogenic in rats tested in the black-white box.

J W Smythe1, D Murphy, S Bhatnagar, C Timothy, B Costall.   

Abstract

Central cholinergic (ACh) projections have been shown to modulate stress-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis and are integral to the expression of electrophysiological correlates of arousal, namely hippocampal theta rhythm. The degree to which these actions of ACh are behaviorally relevant has received comparatively less attention, and we sought to investigate if manipulations of ACh systems might also affect behaviors related to stress and arousal. We chose to examine indices of anxiety as revealed by changes in behavior elicited by the black-white box test, a relatively novel and recently validated model of rodent anxiety. Groups of rats were injected with either scopolamine hydrobromide (SCOP; 0, 0.05, and 0.10 mg/kg i.p.) or the peripherally acting scopolamine methyl bromide (methyl-SCOP; 0, 0.05, and 0.10 mg/kg i.p.) to compare and contrast the effects of central and peripheral ACh blockade on measures of anxiety. SCOP pretreatment significantly lowered latencies for rats to escape from the white to black compartment, while methyl-SCOP elevated latencies to reenter the white chamber from the black. Both drugs increased the amount of time rats spent in the black compartment and also suppressed exploration as revealed by decreased episodes of intercompartmental locomotion. Neither drug deleteriously affected locomotor activity, however; in fact, SCOP significantly increased locomotion in the white chamber. In the absence of motor disturbances to account for any group differences, we contend that both central and peripheral ACh blockade may affect measures of anxiety, perhaps by directly or indirectly affecting HPA activity. Central ACh systems may underlie sensory filtering whereby irrelevant stimuli are excluded from sensory processing. Antagonism of ACh transmission may render an animal incapable of correctly processing sensory information leading to hyperresponsiveness, which can manifest itself as enhanced anxiety and fear.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8728539     DOI: 10.1016/0091-3057(95)02130-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor.

Authors:  T Miyakawa; M Yamada; A Duttaroy; J Wess
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Cholinergic blockade reduces theta-gamma phase amplitude coupling and speed modulation of theta frequency consistent with behavioral effects on encoding.

Authors:  Ehren L Newman; Shea N Gillet; Jason R Climer; Michael E Hasselmo
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

3.  Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice.

Authors:  Tracy A Bedrosian; Kamillya L Herring; Zachary M Weil; Randy J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 4.  Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.

Authors:  Susanne Graef; Peter Schönknecht; Osama Sabri; Ulrich Hegerl
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

5.  Roles of p75(NTR), long-term depression, and cholinergic transmission in anxiety and acute stress coping.

Authors:  Keri Martinowich; Robert J Schloesser; Yuan Lu; Dennisse V Jimenez; Daniel Paredes; Joshua S Greene; Nigel H Greig; Husseini K Manji; Bai Lu
Journal:  Biol Psychiatry       Date:  2011-10-05       Impact factor: 13.382

6.  Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine.

Authors:  Serena Deiana; Charles R Harrington; Claude M Wischik; Gernot Riedel
Journal:  Psychopharmacology (Berl)       Date:  2008-11-14       Impact factor: 4.530

7.  Blockade of muscarinic receptors impairs the retrieval of well-trained memory.

Authors:  Shogo Soma; Naofumi Suematsu; Satoshi Shimegi
Journal:  Front Aging Neurosci       Date:  2014-04-08       Impact factor: 5.750

8.  High Resolution UHPLC-MS Metabolomics and Sedative-Anxiolytic Effects of Latua pubiflora: A Mystic Plant used by Mapuche Amerindians.

Authors:  Eliana L Sánchez-Montoya; Marco A Reyes; Joel Pardo; Juana Nuñez-Alarcón; José G Ortiz; Juan C Jorge; Jorge Bórquez; Andrei Mocan; Mario J Simirgiotis
Journal:  Front Pharmacol       Date:  2017-07-26       Impact factor: 5.810

9.  Central Administration of Ampelopsin A Isolated from Vitis vinifera Ameliorates Cognitive and Memory Function in a Scopolamine-Induced Dementia Model.

Authors:  Yuni Hong; Yun-Hyeok Choi; Young-Eun Han; Soo-Jin Oh; Ansoo Lee; Bonggi Lee; Rebecca Magnan; Shi Yong Ryu; Chun Whan Choi; Min Soo Kim
Journal:  Antioxidants (Basel)       Date:  2021-05-24

10.  Establishing zebrafish as a model to study the anxiolytic effects of scopolamine.

Authors:  Trevor J Hamilton; Adam Morrill; Kayla Lucas; Joshua Gallup; Megan Harris; Meghan Healey; Taylor Pitman; Melike Schalomon; Shannon Digweed; Martin Tresguerres
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.